486-63-5
486-63-5
Chemical Structure
Isoformononetin
- CAS No.: 486-63-5
- Formula:C16H12O4
- Molecular Weight:268.26
IUPAC Name: 3-(4-hydroxyphenyl)-7-methoxy-4H-chromen-4-one
InChIKey: LNIQZRIHAMVRJA-UHFFFAOYSA-N
SMILES: O=C1C(C2=CC=C(O)C=C2)=COC3=CC(OC)=CC=C13
Biological Activity: Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Isoformononetin | 99.47% | Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isoformononetin (Standard) | ≥98% | Isoformononetin (Standard) is the analytical standard of Isoformononetin. This product is intended for research and analytical applications. Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Isoformononetin-d3 | 98.64% | Isoformononetin-d3 is the deuterium labeled Isoformononetin (HY-N7501). Isoformononetin is an analog of Daidzein (HY-N0019) and has immunoprotective effects. Isoformononetin inhibits the differentiation of Th17 and B-cells lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
